Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites

Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementa...

Descripción completa

Detalles Bibliográficos
Autores principales: Christopoulos, Katerina A, Colasanti, Jonathan, Johnson, Mallory O, Diaz Tsuzuki, Manami, Erguera, Xavier A, Flores, Rey, Kerman, Jared, Dance, Kaylin, Sauceda, John A, Neilands, Torsten B, Dilworth, Samantha E, Koester, Kimberly A, Gutierrez, Jose, Schneider, John A, Montgomery, Elizabeth, McNulty, Moira C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301580/
https://www.ncbi.nlm.nih.gov/pubmed/35873299
http://dx.doi.org/10.1093/ofid/ofac293
Descripción
Sumario:Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.

Ejemplares similares